Lyumjev ® ▼ (insulin lispro)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Lyumjev Summary of Product Characteristics (SmPC)

Lyumjev® ▼ (insulin lispro): Transitioning From Prandial or Other Insulins

If converting from another mealtime insulin to Lyumjev, the change can be done on a unit-to-unit basis.

Detailed Information

If transitioning from another mealtime insulin to Lyumjev, the change can be done on a unit-to-unit basis.1

Individualize and adjust the dosage of Lyumjev based on

  • the patient’s metabolic needs

  • BG monitoring results, and

  • glycemic control goal.1  

To minimize the risk of hypoglycemia or hyperglycemia, Lyumjev dose adjustments may be needed

  • when transitioning from another insulin

  • when changes in physical activity

  • when changes in concomitant medications

  • when changes in meal patterns such as amount and type of food, timing of food intake

  • changes in renal or hepatic function, or

  • during acute illness.1

References

1. Lyumjev [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

Glossary

BG = blood glucose

URLi = ultra rapid lispro

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Date of Last Review: January 16, 2020


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 8am - 4pm, excluding Bank Holidays

Or you can

Chat with Us If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a question